Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

WHO position on measles vaccines.

World Health Organization.

Vaccine. 2009 Dec 9;27(52):7219-21. doi: 10.1016/j.vaccine.2009.09.116. Epub 2009 Oct 13.

PMID:
19833246
2.

[Global immunization policies and recommendations: objectives and process].

Duclos P, Okwo-Bele JM.

Med Sci (Paris). 2007 Apr;23(4):409-16. Review. French.

3.

Principles of measles control.

Cutts FT, Henderson RH, Clements CJ, Chen RT, Patriarca PA.

Bull World Health Organ. 1991;69(1):1-7. Review.

4.

The unfinished measles immunization agenda.

Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S.

J Infect Dis. 2003 May 15;187 Suppl 1:S1-7. Review.

PMID:
12721885
5.

[Ambitious measles vaccination program in Vietnam].

Björklund J, Strand M, Blennow M.

Lakartidningen. 2006 Apr 26-May 2;103(17):1325-7. Review. Swedish. No abstract available.

PMID:
16708862
6.

Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.

Uzicanin A, Zimmerman L.

J Infect Dis. 2011 Jul;204 Suppl 1:S133-48. doi: 10.1093/infdis/jir102. Review.

PMID:
21666154
7.

The impact of immunization control activities on measles outbreaks in middle and low income countries.

Aylward RB, Clements J, Olivé JM.

Int J Epidemiol. 1997 Jun;26(3):662-9. Review.

PMID:
9222794
8.

Two-dose measles vaccination schedules.

Rosenthal SR, Clements CJ.

Bull World Health Organ. 1993;71(3-4):421-8. Review.

9.

Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts on immunization.

Duclos P, Okwo-Bele JM, Salisbury D.

Expert Rev Vaccines. 2011 Feb;10(2):163-73. doi: 10.1586/erv.10.171. Review.

PMID:
21332266
10.

Measles and rubella in the World Health Organization European region: diversity creates challenges.

Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.

J Infect Dis. 2003 May 15;187 Suppl 1:S191-7. Review.

PMID:
12721913
11.

Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.

Pless RP, Bentsi-Enchill AD, Duclos P.

J Infect Dis. 2003 May 15;187 Suppl 1:S291-8. Review.

PMID:
12721928
12.

Immunization of children at risk of infection with human immunodeficiency virus.

Moss WJ, Clements CJ, Halsey NA.

Bull World Health Organ. 2003;81(1):61-70. Epub 2003 Mar 11. Review.

13.

[Routine vaccinations in children and adults infected with HIV].

Dabis F, Lepage P, Msellati P, Van de Perre P, Nsengumuremyi F, Hitimana DG, Ladner J, Leroy V.

Sante. 1994 May-Jun;4(3):173-82. Review. French.

14.

Measles control in the United States: problems of the past and challenges for the future.

Wood DL, Brunell PA.

Clin Microbiol Rev. 1995 Apr;8(2):260-7. Review.

15.

Measles vaccine: do we need new vaccines or new programs?

Katz SL, Gellin BG.

Science. 1994 Sep 2;265(5177):1391-2. Review. No abstract available.

PMID:
8073281
16.

Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons.

Poland GA, Jacobson RM.

Arch Intern Med. 1994 Aug 22;154(16):1815-20. Review.

PMID:
8053748
17.

Measles immunization research: a review.

Aaby P, Clements CJ.

Bull World Health Organ. 1989;67(4):443-8. Review.

18.

Monitoring the interruption of indigenous measles transmission, Cape Town meeting, 14 October 2003.

[No authors listed]

Wkly Epidemiol Rec. 2004 Feb 13;79(7):70-2. Review. English, French. No abstract available.

PMID:
15024852

Supplemental Content

Support Center